News 03.01.17

Back at Pivot Park: Vivenics

Vivenics provides consultancy and software services for data management and data integrity.

Read more
News 20.12.16

Results from the Phase I/II ACE-CL-001 clinical trial of acalabrutinib

AstraZeneca and Acerta Pharma announce results from the Phase I/II ACE-CL-001 clinical trial of acalabrutinib.

Read more
News 06.12.16

NTRC’s Oncolines™ profiling is cover story in December issue of Molecular Cancer Therapeutics

An analysis by NTRC of 122 anti-cancer agents is cover story of Molecular Cancer Therapeutics.

Read more
News 01.12.16

PRIO Pharma launched at BIO Europe

PRIO pharma enables drug development innovations by co-creation.

Read more
News 01.12.16

New at Pivot Park: Mr. Pepper

“We are the Mr. Pepper company, the first independent distributor of social robotics solutions in the Netherlands.”

Read more
News 30.11.16

Dutch scientists honoured for Immuno Oncology Drug Development

Dutch scientists Hans van Eenennaam and John Dulos were part of the team that discovered KEYTRUDA.

Read more
News 14.11.16

Review – Topsector Cross-over Event

On the first of November the Topsector cross-over Event took place at Pivot Park.

Read more
News 20.10.16

Synaffix Enters into a Commercial License Agreement with ADC Therapeutics

Synaffix BV announced today it has entered into a Commercial License Agreement with ADC Therapeutics for its proprietary GlycoConnect™ and HydraSpace™ site-specific antibody-drug conjugate technologies.

Read more
News 17.10.16

BioConnection wins FD Gazellen Award

BioConnection proudly announced that it has won the FD Gazellen status.

Read more